BTIG Research Cuts NRx Pharmaceuticals (NASDAQ:NRXP) Price Target to $10.00

Дата публикации: 10-08-2026 05:48:47

NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) had its price objective lowered by BTIG Research to $10.00 in a research report released on Friday,Benzinga reports. BTIG Research currently has a buy rating on the stock. A number of other brokerages also recently issued reports on NRXP. D. Boral Capital restated a “buy” rating and set a […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Needham & Company LLC Cuts TechTarget (NASDAQ:TTGT) Price Target to $8.00	0	13	10-08-2026
2	Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00	0	13.82	10-08-2026
3	Texas Roadhouse (NASDAQ:TXRH) Price Target Raised to $220.00	0	11.48	10-08-2026
4	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
5	Xperi’s (XPER) “Buy” Rating Reiterated at BWS Financial	0	7.11	10-08-2026
6	Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $175.00	0	12.26	10-08-2026
7	NexPoint Real Estate Finance (NYSE:NREF) Price Target Raised to $17.50	0	10.14	10-08-2026
8	Stephens Cuts Rocket Companies (NYSE:RKT) Price Target to $20.00	0	10.12	10-08-2026
9	Guggenheim Cuts Zevra Therapeutics (NASDAQ:ZVRA) Price Target to $23.00	0	9.15	10-08-2026
10	Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00	0	14.22	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.08. Источник: www.americanbankingnews.com.